Admiring how they have handled the news/result, did as they said they would by withdrawing it from sale, allowing existing patients to continue taking it for free if the want to, yes cutting staff numbers (with full entitlements) would be an expected out for a company with no other income.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1112
-
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $95.68M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 21.5¢ | $174.1K | 799.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 59616 | 3 |
View Market Depth
| Last trade - 13.48pm 16/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |